Posts

Posted on

Nancy L. Cho, MD, Appointed Section Chief of Endocrine Surgery in the Division of Surgical Oncology at Brigham and Women’s Hospital

NANCY L. CHO, MD
Section Chief, Endocrine Surgery, Division of Surgical Oncology, Department of Surgery
Associate Clerkship Director, Harvard Medical School Core Surgery Rotation
Assistant Professor, Harvard Medical School

Dr. Cho received her AB from Harvard University and MD from Columbia University College of Physicians and Surgeons. She completed residency training in general surgery and fellowship training in endocrine surgery at the Brigham. She is an associate surgeon in the division and an assistant professor of surgery at Harvard Medical School. Dr. Cho also serves as associate clerkship director for the Surgery Clerkship at the Brigham.

Her clinical interests include endocrine diseases of the thyroid/parathyroid glands and melanoma. Her current research focuses on investigating gender disparities in academic surgery, including award recognition, operative experience, conference speakers and society leadership. Dr. Cho has also published extensively on clinical outcomes in endocrine surgery to optimize delivery of patient care and improve surgical practices. She currently serves on committees for the American Association of Endocrine Surgeons, the Society of Asian Academic Surgeons and the Association for Academic Surgery.

Posted on

Welcoming New Faculty – Devin O’Brien Coon, MD, MSE

Please join us in welcoming Devin O’Brien Coon, MD, MSE, as a new faculty member in the Department of Surgery.

Devin O’Brien Coon, MD, MSE
Associate Surgeon, Division of Plastic and Reconstructive Surgery
Surgical and Clinical Director, Brigham Center for Transgender Health

Dr. Coon joins the Brigham from Johns Hopkins University, where he was associate professor of plastic surgery and biomedical engineering. He attended college and medical school at the University of Pittsburgh and holds a master’s in biomedical engineering from Johns Hopkins University. He completed integrated plastic surgery training at the Johns Hopkins/UMD Shock Trauma Center program and is board certified in plastic and reconstructive surgery.

Before joining the Brigham, Dr. Coon also served as the founding chief medical director of the Johns Hopkins Center for Transgender Health, where he developed a multidisciplinary service line across eight departments that became one of the largest academic programs in the U.S. He is recognized as a leader in genitourinary salvage procedures and is frequently referred secondary revision cases. He initiated and directed the Johns Hopkins Complex Gender & Microsurgery Fellowship. He will serve as inaugural clinical and surgical director of the new Brigham Center for Transgender Health.

Dr. O’Brien directs a basic science lab focusing on cutaneous repair, fibrosis and regeneration, as well as sex hormone-mediated control of wound healing and scarring. He is also interested in biomedical innovation and has invented and successfully translated two FDA-approved medical devices (a bioresorbable implant and a 3D ultrasound system) to clinical use.

His primary clinical areas are facial gender surgery, facial aesthetic surgery, genital gender-affirming surgery and genital/pelvic reconstruction for revision or oncologic patients.

Posted on

Thomas E. Clancy, MD, Named Distinguished Scholar in Surgical Oncology at Brigham and Women’s Hospital

Thomas E. Clancy, MD, has been named the inaugural Distinguished Scholar in Surgical Oncology at Brigham and Women’s Hospital thanks to a gift from Carmella R. Kletjian.

Thomas E. Clancy, MD
Associate Surgeon, Division of Surgical Oncology, Brigham and Women’s Hospital
Co-Director, Pancreatic and Biliary Tumor Center, Dana-Farber/Brigham and Women’s Cancer Center
Director, Program in Robotic/Minimally Invasive Pancreatic and Liver Surgery
Medical Director, Multispecialty Surgical Oncology, DF/BWCC in clinical affiliation with South Shore Hospital
Assistant Professor, Harvard Medical School

Dr. Clancy is a senior surgeon and Distinguished Scholar in Surgical Oncology in the Department of Surgery at Brigham and Women’s Hospital, where he is also the director of the Program in Robotic/Minimally Invasive Pancreatic and Liver Surgery. He is a senior staff member and surgical lead at the Gastrointestinal Cancer Center at Dana-Farber Cancer Institute and co-director of the Pancreas and Biliary Tumor Center at the Dana-Farber/Brigham and Women’s Cancer Center. Dr. Clancy received his medical degree from Harvard Medical School and completed general surgical residency at Brigham and Women’s Hospital, followed by a surgical oncology fellowship at Brigham and Women’s Hospital and Dana-Farber Cancer Institute.

Dr. Clancy specializes in surgery for complex gastrointestinal malignancies, with a focus on pancreatic tumors, primary and metastatic liver tumors, biliary malignancies and neuroendocrine tumors. He has a particular focus on minimally invasive and robotic surgical techniques for gastrointestinal tumors.

An author of over 75 scientific publications, reviews and book chapters, Dr. Clancy works in a collaborative model with numerous basic and translational scientific researchers on projects related to the diagnosis and management of gastrointestinal malignancies and pancreatic disease, as well as clinical outcomes in pancreatic surgery.